Login / Signup

Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.

Nidah Shabbir KhakooShahnaz SultanJohn M ReynoldsCynthia Levy
Published in: Digestive diseases and sciences (2022)
Use of BZF alone or in combination with UDCA improved liver biochemistries in patients with PBC, but its effect on mortality, liver-related complications or quality of life remains unknown.
Keyphrases
  • risk factors
  • cardiovascular disease
  • coronary artery disease
  • ulcerative colitis